Does soluble receptor for advanced glycation end products alleviate nephritis in ( NZB/NZW ) F1 mice?
Treatment with sRAGE significantly improved nephritis in lupus-prone mice, with efficacy comparable to that of standard induction treatment for lupus nephritis. These data suggest that sRAGE has antiinflammatory effects on the pathophysiology of lupus nephritis and could serve as a potent new therapy for this disease.
This study provides genetic evidence linking CCR2 with coronary atherosclerosis in humans.